Simplex Trading’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Simplex Trading’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-16,300	Closed	-$73K	–	11975
2021 Q4	$73K	Buy	16,300 +13,800	+552%	+$392K	﹤0.01%	6728
2021 Q3	$94K	Hold	2,500	–	–	﹤0.01%	6712
2021 Q2	$93K	Buy	2,500 +2,496	+62,400%	+$76.5K	﹤0.01%	6846
2021 Q1	$10K	Sell	4 -89	-96%	-$2.27K	﹤0.01%	7918
2020 Q4	$204K	Buy	93 +62	+200%	+$1.37K	﹤0.01%	4575
2020 Q3	$55K	Buy	31 +28	+933%	+$580	﹤0.01%	5521
2020 Q2	$7K	Sell	3 -1	-25%	-$22	﹤0.01%	6868
2020 Q1	$7K	Sell	4 -8	-67%	-$155	﹤0.01%	6718
2019 Q4	$26K	Buy	+12	New	+$241	﹤0.01%	5774
2019 Q2	–	Sell	-1	Closed	-$1K	–	8130
2019 Q1	$1K	Buy	+1	New	+$11	﹤0.01%	6988
2018 Q2	–	Sell	-4	Closed	-$2K	–	8106
2018 Q1	$2K	Sell	4 -156	-98%	-$1.68K	﹤0.01%	5422
2017 Q4	$30K	Buy	+160	New	+$1.18K	﹤0.01%	2939

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Simplex Trading's DRNA Position: Q4 2021 in Review

Simplex Trading sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 1,759 shares — an estimated $50K sold.

Simplex Trading first reported a position in DRNA in Q2 2018 and held it in 9 quarters. The position peaked at $636K in Q3 2020. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Simplex Trading reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Simplex Trading sold 1,759 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $50K.
Simplex Trading first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2018 and held it in 9 quarters.
Simplex Trading's Dicerna Pharmaceuticals, Inc. position peaked at $636K in Q3 2020.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Simplex Trading's 13F filing for Q4 2021, filed 4 Feb 2022.